Sparsh Stem Cell Private Limited - Due diligence report

A 360° intelligence report on Sparsh Stem Cell Private Limited: trust score, financial health, credit view, compliance, directors, growth an…

2013-08-19 Mumbai, Maharashtra Active Unlisted Active Non-Compliant
Share
SS Sparsh Stem Cell Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sparsh Stem Cell Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Sparsh Stem Cell Private Limited is assessed as Low Risk with a Trust Score of 78/100. Sparsh Stem Cell Private Limited is an active private limited indian non-government company incorporated in 2013, operating in the Trading sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 22 Jul 2026 from the latest processed filings. Sparsh Stem Cell Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
55/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 55/100 Moderate
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2017 - filings overdue.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
DINESHKUMAR GAHARILAL JAIN 01234567 Director 01/04/2018 6 yrs Approved
RINKU DINESH JAIN 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
5 allotment(s) · 0 transfer(s)

Promoters hold a minority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 80
Growth signals & trust indicators
Operating for 12+ years.
Distress signals & risk flags
Statutory filings appear overdue.
Compliance score is weak (55/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence69/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view49/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 10 events
29 Sep 2017
Last AGM held
Annual general meeting
31 Mar 2017
Latest balance sheet
Filed with ROC
29 Mar 2014
Securities allotted
124000.00 Equity Shares - 12.40 Lakh raised
Securities allotted
137000.00 Equity Shares - 13.70 Lakh raised
Securities allotted
110000.00 Equity Shares - 11.00 Lakh raised
Securities allotted
99000.00 Equity Shares - 9.90 Lakh raised
Securities allotted
58000.00 Equity Shares - 5.80 Lakh raised
19 Aug 2013
Incorporated
Registered with Roc Mumbai
Director appointed
DINESHKUMAR GAHARILAL JAIN (Director)
Director appointed
RINKU DINESH JAIN (Director)
10

Key Observations

Auto-generated from the data above
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a minority stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 5 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Rushabh Medi-Surge Hospitals Private Limited U85110GJ2011PTC063463 Ahmedabad, Gujarat, India
Arik Lifescience Private Limited U36993BR2015PTC024096 Dehri, Bihar, India
Gupta Press Panjika Private Limited U22219WB1999PTC088719 Kolkata, West Bengal, India
Wise Machines India Private Limited U72200KA2013PTC069252 Bangalore, Karnataka, India
Yellow Boy Retail Services Private Limited U51102KA2013PTC070994 Bengaluru, Karnataka, India
Mahar Silver Wares Private Limited U51398KL2010PTC026931 Malappuram, Kerala, India
Bhaap Online Retail Private Limited U52390KA2011PTC060472 Bangalore, Karnataka, India
Metropolis Health Products Retail Private Limited U52310MH2013PTC240875 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sparsh Stem Cell Private Limited before audits and certifications: compliance score 55/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sparsh Stem Cell Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Sparsh Stem Cell Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Sparsh Stem Cell Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Sparsh Stem Cell Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sparsh Stem Cell Private Limited an active company?

Sparsh Stem Cell Private Limited has MCA status “Active” with a compliance score of 55/100 (Moderate).

Is Sparsh Stem Cell Private Limited financially healthy?

Sparsh Stem Cell Private Limited has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Sparsh Stem Cell Private Limited?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sparsh Stem Cell Private Limited?

Promoters hold a minority stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Sparsh Stem Cell Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Sparsh Stem Cell Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 55/100 (Moderate).

Is it risky to lend to Sparsh Stem Cell Private Limited?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.